Monday, March 18, 2024
ISSN 2765-8767
  • Home
  • About Us
  • Contact us
  • Support Us
  • Home
  • About Us
  • Contact us
  • Support Us

Diabetes type 2 prioritized over diabetes type 1 in CDC prioritization schedule

Guidelines from the Centers for Disease Control and Preventions released in December rank a person with type 2 diabetes as someone who “is at increased risk” of more severe illness from COVID-19. That means people with that condition will follow health care workers and people living in long-term care settings, getting their vaccines in Phase 1c of the rollout. Data behind that ranking are considered “strongest and most consistent evidence.”

People with type 1 diabetes are in Phase 2, deemed to be patients who “might be at an increased risk” for severe illness. Data behind that ranking are classified as “limited evidence.”

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Why are health insurance premiums going up?

How do you envision death?

How do you envision death?

As society entered the era of modern medicine, people developed a new understanding of death. Artist John Downman portrays two star-crossed lovers meeting for the last time: Edwin and Emma. For these two lovers, death is a welcomed reprieve from a life of sadness and separation.

Read more

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do